Urine Bladder Cancer Test Could Triage Cystoscopy

• September 11, 2026

FDA approves serial liquid biopsy testing

In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.

• by Kathryn Wighton

• September 8, 2026

• 2 min

Mild metabolic profile may mask MASLD risk

Five reproducible MASLD subtypes showed distinct genetic profiles and patterns of metabolic comorbidity and disease progression.

• by Andrea Surnit

• September 10, 2026

• 4 min

Educators weigh how to use AI without losing critical thinking

Greater productivity is not necessarily indicative of greater knowledge.

• by Julia Cipriano, MS, CMPP

• September 10, 2026

• 8 min